Browsing by Author Arribillaga, L. (Laura)

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 17 of 17
Issue DateTitleTypeAuthor(s)
2013A fusion protein between streptavidin and the endogenous TLR4 ligand EDA targets biotinylated antigens to dendritic cells and induces T cell responses in vivoArticuloLasarte, J.J. (Juan José); Prieto, J. (Jesús); Sarobe, P. (Pablo); Borras-Cuesta, F. (Francisco); Gorraiz, M. (Marta); Martinez, M. (Marta); Villanueva, L. (Lorea); Casares, N. (Noelia); Rehberger-Bescos, F. (Federico); Rudilla, F. (Francesc); Lozano-Moreda, T. (Teresa); Durantez, M. (Maika); Arribillaga, L. (Laura)
25-Nov-2010A peptide inhibitor of FOXP3 impairs regulatory T cell Activity and improves vaccine efficacy in miceArticuloCasares, N. (Noelia); Rudilla, F. (Francesc); Arribillaga, L. (Laura); Llopiz, D. (Diana); Riezu-Boj, J.I. (José Ignacio); Lozano-Moreda, T. (Teresa); Lopez-Sagaseta, J. (Jacinto); Guembe, L. (L.); Sarobe, P. (Pablo); Prieto, J. (Jesús); Borras-Cuesta, F. (Francisco); Lasarte, J.J. (Juan José)
2003A recombinant adenovirus encoding hepatitis C virus core and E1 proteins protects mice against cytokine-induced liver damageArticuloLasarte, J.J. (Juan José); Sarobe, P. (Pablo); Boya, P. (Patricia); Casares, N. (Noelia); Arribillaga, L. (Laura); Lopez-Diaz-de-Cerio, A. (Ascensión); Gorraiz, M. (Marta); Borras-Cuesta, F. (Francisco); Prieto, J. (Jesús)
2020Bivalent therapeutic vaccine against HPV16/18 genotypes consisting of a fusion protein between the extra domain A from human fibronectin and HPV16/18 E7 viral antigensArticuloArribillaga, L. (Laura); Echeverria, I. (Itziar); Belsue, V. (Virginia); Gomez, T. (Timothy); Lozano-Moreda, T. (Teresa); Casares, N. (Noelia); Villanueva, L. (Lorea); Domingos-Pereira, S. (Sonia); Romero, P.J. (Pedro J.); Nardelli-Haefliger, D. (Denise); Hervas-Stubbs, S. (Sandra); Sarobe, P. (Pablo); Rodriguez, M.J. (María Josefa); Carrascosa, J.L. (José L.); Zürcher, T. (Thomas); Lasarte, J.J. (Juan José)
2003CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccinationArticuloCasares, N. (Noelia); Arribillaga, L. (Laura); Sarobe, P. (Pablo); Dotor, J. (Javier); Lopez-Diaz-de-Cerio, A. (Ascensión); Melero, I. (Ignacio); Lasarte, J.J. (Juan José)
2012Combination of a TLR4 ligand and anaphylatoxin C5a for the induction of antigen-specific cytotoxic T cell responsesArticuloRudilla, F. (Francesc); Fayolle, C. (Catherine); Casares, N. (Noelia); Durantez, M. (Maika); Arribillaga, L. (Laura); Lozano-Moreda, T. (Teresa); Villanueva, L. (Lorea); Pio, R. (Rubén); Sarobe, P. (Pablo); Leclerc, C. (Claude); Prieto, J. (Jesús); Lasarte, J.J. (Juan José)
2005Enhancement of CD4 and CD8 immunity by anti-CD137 (4-1BB) monoclonal antibodies during hepatitis C vaccination with recombinant adenovirusArticuloArribillaga, L. (Laura); Sarobe, P. (Pablo); Arina, A. (Ainhoa); Gorraiz, M. (Marta); Borras-Cuesta, F. (Francisco); Ruiz, J. (Juan); Prieto, J. (Jesús); Chen, L. (Lieping); Melero, I. (Ignacio); Lasarte, J.J. (Juan José)
2011Eradication of large tumors expressing human papillomavirus E7 protein by therapeutic vaccination with E7 fused to the extra domain a from fibronectinArticuloMansilla, C. (Cristina); Berraondo, P. (Pedro); Durantez, M. (Maika); Martinez, M. (Marta); Casares, N. (Noelia); Arribillaga, L. (Laura); Rudilla, F. (Francesc); Fioravanti, J. (Jessica); Lozano-Moreda, T. (Teresa); Villanueva, L. (Lorea); Sarobe, P. (Pablo); Borras-Cuesta, F. (Francisco); Leclerc, C. (Claude); Prieto, J. (Jesús); Lasarte, J.J. (Juan José)
2003Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responsesArticuloSarobe, P. (Pablo); Lasarte, J.J. (Juan José); Zabaleta, A. (Aintzane); Arribillaga, L. (Laura); Arina, A. (Ainhoa); Melero, I. (Ignacio); Borras-Cuesta, F. (Francisco); Prieto, J. (Jesús)
2009Immunization against hepatitis C virus with a fusion protein containing the extra domain A from fibronectin and the hepatitis C virus NS3 proteinArticuloMansilla, C. (Cristina); Gorraiz, M. (Marta); Martinez, M. (Marta); Casares, N. (Noelia); Arribillaga, L. (Laura); Rudilla, F. (Francesc); Echeverria, I. (Itziar); Riezu-Boj, J.I. (José Ignacio); Sarobe, P. (Pablo); Borras-Cuesta, F. (Francisco); Prieto, J. (Jesús); Lasarte, J.J. (Juan José)
2007Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40ArticuloZabaleta, A. (Aintzane); Arribillaga, L. (Laura); Llopiz, D. (Diana); Dotor, J. (Javier); Lasarte, J.J. (Juan José); Prieto, J. (Jesús); Borras-Cuesta, F. (Francisco); Esteban, J.I. (Juan Ignacio); Quer, J. (Josep); Vayreda, F. (Francesc); Sarobe, P. (Pablo)
2007The extra domain A from fibronectin targets antigens to TLR4-expressing cells and induces cytotoxic T cell responses in vivoArticuloLasarte, J.J. (Juan José); Casares, N. (Noelia); Gorraiz, M. (Marta); Hervas-Stubbs, S. (Sandra); Arribillaga, L. (Laura); Mansilla, C. (Cristina); Durantez, M. (Maika); Llopiz, D. (Diana); Sarobe, P. (Pablo); Borras-Cuesta, F. (Francisco); Prieto, J. (Jesús); Leclerc, C. (Claude)
2012The extradomain A of fibronectin (EDA) combined with poly(I:C) enhances the immune response to HIV-1 p24 protein and the protection against recombinant Listeria monocytogenes-Gag infection in the mouse modelArticuloSan-Roman, B. (Beatriz); Andres, X. (Ximena) de; Muñoz, P. (Pilar); Obregon, P. (Patricia); Asensio, A.C. (Aaron C.); Garrido, V. (Victoria); Mansilla, C. (Cristina); Arribillaga, L. (Laura); Lasarte, J.J. (Juan José); Andres, D. (D.) de; Amorena, B. (Beatriz); Grillo, M.J. (María Jesús)
2006The immunotherapy potential of agonistic anti-CD137 (4-1BB) monoclonal antibodies for malignancies and chronic viral diseasesArticuloAlfaro, C. (Carlos); Murillo, O. (Oihana); Tirapu, I. (Íñigo); Azpilicueta, A. (Arantza); Huarte, E. (Eduardo); Arina, A. (Ainhoa); Arribillaga, L. (Laura); Perez-Gracia, J.L. (Jose Luis); Bendandi, M. (Maurizio); Prieto, J. (Jesús); Lasarte, J.J. (Juan José); Melero, I. (Ignacio)
2011Therapeutic effect of a peptide inhibitor of TGF-β on pulmonary fibrosisArticuloArribillaga, L. (Laura); Dotor, J. (Javier); Basagoiti, M. (María); Riezu-Boj, J.I. (José Ignacio); Borras-Cuesta, F. (Francisco); Lasarte, J.J. (Juan José); Sarobe, P. (Pablo); Cornet, M.E. (María Eugenia); Feijoo, E. (Esperanza)
2008Vaccination against hepatitis C virus with dendritic cells transduced with an adenovirus encoding NS3 proteinArticuloZabaleta, A. (Aintzane); Llopiz, D. (Diana); Arribillaga, L. (Laura); Silva, L. (Leyre); Riezu-Boj, J.I. (José Ignacio); Lasarte, J.J. (Juan José); Borras-Cuesta, F. (Francisco); Prieto, J. (Jesús); Sarobe, P. (Pablo)
2002Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virusArticuloArribillaga, L. (Laura); Lopez-Diaz-de-Cerio, A. (Ascensión); Sarobe, P. (Pablo); Casares, N. (Noelia); Gorraiz, M. (Marta); Vales, A. (África); Bruña-Romero, O. (Oscar); Borras-Cuesta, F. (Francisco); Paranhos-Baccala, G. (Glaucia); Prieto, J. (Jesús); Ruiz, J. (Juan); Lasarte, J.J. (Juan José)